Clinical Aspects of Multiple Sclerosis Essentials and Current Updates

Erscheinungsjahr 2024
ISBN: 978-0-323-95343-6
Verlag: Elsevier Science

Buch, Englisch, 402 Seiten, Format (B × H): 152 mm x 229 mm, Gewicht: 650 g

Clinical Aspects of Multiple Sclerosis Essentials and Current Updates offers readers a comprehensive and up-to-date analysis of multiple sclerosis (MS) and its related disorders, providing the latest research findings and insights to ensure readers are well informed. This book thoroughly examines the underlying genetic factors contributing to the development of the disease while emphasizing the significant role of vitamin D in both the pathogenesis and treatment of MS. Furthermore, this book provides essential information on current treatment guidelines for effectively managing MS during pregnancy. This includes a specific focus on optimizing outcomes and addressing the complexities involved, healthcare professionals are equipped to handle the challenges presented by this specific patient population. Overall, this book delivers meticulous, updated, and extensive information on all aspects of MS, from demographic features and etiopathogenesis to the latest diagnostic and therapeutic interventions. With a focus on delivering valuable knowledge and practical insights, Clinical Aspects of Multiple Sclerosis Essentials and Current Updates serves as an essential resource for healthcare professionals and researchers seeking a deeper understanding of MS.

Autoren/Hrsg.

Sriwastava, Shitiz

Bernitsas, Evanthia

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Neurologie, Klinische Neurowissenschaft
• Interdisziplinäres Wissenschaften Wissenschaften Interdisziplinär Neurowissenschaften, Kognitionswissenschaft
• Naturwissenschaften Biowissenschaften Biowissenschaften Genetik und Genomik (nichtmedizinisch)

Inhaltsverzeichnis

- Introduction of multiple sclerosis and its subtypes, including the new terms clinically isolated syndrome and radiologically isolated syndrome, and diagnostic criteria including McDonald 2017 updates
- Introduction to neuromyelitis optica spectrum disorders
- Multiple sclerosis epidemiology, epigenetics, and causative factors
- Nonmultiple sclerosis demyelinating disorders and common mimickers and masquerading of multiple sclerosis
- Current and emerging therapies in multiple sclerosis and practice guidelines
- Pediatric multiple sclerosis and current guidelines on DMT therapy in pediatric MS
- Prepregnancy, pregnancy, and postpregnancy planning in patients with multiple sclerosis
- Rare variant of multiple sclerosis
- Imaging of multiple sclerosis, related disorders, and emerging concepts
- Application of optical coherence tomography and angiography in multiple sclerosis
- Cognitive impairment in multiple sclerosis

Über Autor(innen)

Bernitsas, Evanthia
Evanthia Triantafylou-Bernitsas, MD, joined the Department of Neurology at Wayne State University in 2011. She has completed a neurology residency at Case Western Reserve University and Neuroimmunology Fellowships at the University of Michigan and Baylor College of Medicine. She is the Director of the Multiple Sclerosis Center at Wayne State School of Medicine and Professor of Neurology. Her clinical research focuses on aggressive forms of MS, new immunomodulatory therapies and symptomatic interventions. Dr. Bernitsas directs a very active clinical research program and she is the principal investigator on numerous clinical and investigator-initiated trials. Currently, she serves as the Editor-in Chief in the Neuroimaging section of the Brain Sciences journal. She has published extensively and served in several committees and advisory boards.

Sriwastava, Shitiz
Dr. Shitiz K. Sriwastava, MD, is an Assistant Professor in the Department of Neurology with the Division of Multiple Sclerosis and Neuroimmunology at the University of Texas Health Science Center - Houston (UTHealth). He is a board-certified neurologist specialized in multiple sclerosis (MS). During his fellowship training and residency at Wayne State, he performed clinical research on MS and related autoimmune disorders of the central nervous system. He has had many years of experience in MS related clinical trials as a fellow or co-investigator. Dr. Sriwastava has a keen interest in identifying prognostic markers to predict the initiation and progression of MS especially early neurogenerative changes and also DTI studies in MS. He is currently a member of the American Academy of Neurology. His clinical, basic and translational studies in neuroimmunologic diseases have resulted in 50 peer reviewed papers and reports, published abstracts from national and international meetings.